Ekihiro Seki

Ekihiro Seki is a Clinical Professor at the Charles R. Drew University of Medicine and Science within the Biomedical Science department. His research focuses on liver fibrosis, inflammation, steatohepatitis, and neoplasms, with significant contributions to understanding TLR signaling, mitochondrial dysfunction, and hepatic stellate cell biology.

• Primary Research Areas: Gastroenterology, Molecular Biology, Cell Biology, Metabolism
• Key Subfields: Liver fibrosis, Steatohepatitis, Cancer progression, Inflammatory pathways, Signal transduction, Microbiome interactions

Recent publications highlight his work on:

• Gut-liver axis mechanisms in MASH
• Hyaluronan synthase regulation in liver disease
• Metabolic pathways in fibrosis and carcinogenesis
• Autophagy and mitochondrial quality control
• Toll-like receptor signaling in liver pathology
• Cancer-associated fibroblasts in hepatocarcinogenesis

Trends in his research include:

• Integrating Cell Biology and Metabolism to study liver disease progression
• Exploring Gastroenterology and Neoplasms for therapeutic strategies
• Combining Genetics and Pharmacology to test novel drug targets
• Analyzing Science and Molecular Biology to uncover pathogenic mechanisms

No formal awards or student mentorship information is provided in the dataset. His work spans both human and animal models, emphasizing translational research in liver disease and cancer.